When a patient with wheezes or bronchospasm does not improve after using a prescribed inhaler, what is the recommended EMS action if the protocol allows escalation?

When a patient with wheezes or bronchospasm does not improve after using a prescribed inhaler, what is the recommended EMS action if the protocol allows escalation?

• A. Consider nebulized therapy if protocol allows, reassess, and contact medical control.
• B. Increase the inhaler dose and proceed without reassessment.
• C. Wait 10 minutes and observe without changing therapy.
• D. Administer an oral bronchodilator.

Answer: (A)

When someone has wheezing or bronchospasm and doesn’t improve after using a prescribed inhaler, the next best step is to escalate to nebulized bronchodilator therapy if the protocol allows, then reassess and contact medical control. Nebulized treatments deliver a higher and more continuous dose of medication directly to the airways, which can produce a more pronounced and quicker bronchodilator effect than a metered-dose inhaler used once. Reassessing after the nebulized dose is essential to determine if there’s still inadequate response, requiring further doses or additional actions as ordered by medical control. Reaching out to medical control ensures you have the authority to continue escalation, tailor therapy to the patient’s needs, and monitor for potential side effects such as tachycardia or tremors. Increasing the inhaler dose without reassessment lacks confirmation of response and safety. Waiting and observing without changing therapy delays potentially beneficial treatment. Administering an oral bronchodilator is not typically preferred in the EMS setting due to slower onset, systemic effects, and the need for medical direction or orders.

When someone has wheezing or bronchospasm and doesn’t improve after using a prescribed inhaler, the next best step is to escalate to nebulized bronchodilator therapy if the protocol allows, then reassess and contact medical control. Nebulized treatments deliver a higher and more continuous dose of medication directly to the airways, which can produce a more pronounced and quicker bronchodilator effect than a metered-dose inhaler used once. Reassessing after the nebulized dose is essential to determine if there’s still inadequate response, requiring further doses or additional actions as ordered by medical control. Reaching out to medical control ensures you have the authority to continue escalation, tailor therapy to the patient’s needs, and monitor for potential side effects such as tachycardia or tremors.

Increasing the inhaler dose without reassessment lacks confirmation of response and safety. Waiting and observing without changing therapy delays potentially beneficial treatment. Administering an oral bronchodilator is not typically preferred in the EMS setting due to slower onset, systemic effects, and the need for medical direction or orders.